<- Go Home
Oxford Immunotec Global Limited
As of March 8, 2021, operates as a subsidiary of PerkinElmer (UK) Holdings Limited.
Market Cap
$562.5M
Volume
177.3K
Cash and Equivalents
$160.6M
EBITDA
-$16.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$43.0M
Profit Margin
75.08%
52 Week High
$23.11
52 Week Low
$8.37
Dividend
N/A
Price / Book Value
2.98
Price / Earnings
-34.41
Price / Tangible Book Value
3.03
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$17.9M
Return on Equity
8.19%
Return on Assets
-4.99
Cash and Short Term Investments
$160.6M
Debt
$8.9M
Equity
$191.3M
Revenue
$57.3M
Unlevered FCF
-$7.2M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium